Tag: NASDAQ:GALT

Finance

Market Movers: Galectin Therapeutics Inc. (NASDAQ:GALT), Sagent Pharmaceuticals Inc (NASDAQ:SGNT), Weibo Corp (ADR) (NASDAQ:WB), Qihoo 360 Technology Co Ltd (NYSE:QIHU)

Galectin Therapeutics Inc. (NASDAQ:GALT) will present at the Jefferies 2014 Global Healthcare Conference in New York City. Galectin Therapeutics Inc. (NASDAQ:GALT) stock performance was 3.20% in last session and finished the day at $13.22. Traded volume was 165.10K shares in the last session and the average volume of the stock remained 417.97K shares. The beta of the stock remained 1.62. Galectin Therapeutics Inc. (NASDAQ:GALT) insider … Continue reading Market Movers: Galectin Therapeutics Inc. (NASDAQ:GALT), Sagent Pharmaceuticals Inc (NASDAQ:SGNT), Weibo Corp (ADR) (NASDAQ:WB), Qihoo 360 Technology Co Ltd (NYSE:QIHU)

Jason Knox
Finance

Micro-cap Bulls: Galectin Therapeutics (NASDAQ:GALT), Cinedigm Corp (NASDAQ:CIDM), Aviat Networks (NASDAQ:AVNW), Zhone Technologies (NASDAQ:ZHNE)

Galectin Therapeutics Inc. (NASDAQ:GALT), a young, NASDAQ-traded company is fighting this ailment with GR-MD-02, a new drug with encouraging Phase I clinical-trial results. But Galectin Therapeutics Inc. (NASDAQ:GALT)’s progress comes amid frequent migraines, thanks to federal regulations. Galectin Therapeutics Inc. (NASDAQ:GALT) executive chairman James C. Czirr blames “all three of the bad boys” Sarbanes-Oxley, Dodd-Frank, and the USA Patriot Act’s financial-control provisions. Galectin Therapeutics Inc. … Continue reading Micro-cap Bulls: Galectin Therapeutics (NASDAQ:GALT), Cinedigm Corp (NASDAQ:CIDM), Aviat Networks (NASDAQ:AVNW), Zhone Technologies (NASDAQ:ZHNE)

Kristen Barton
Finance

Healthcare Losers: TearLab Corp (NASDAQ:TEAR), Galectin Therapeutics (NASDAQ:GALT), Fibrocell Science (NYSEMKT:FCSC), BioLife Solutions (NASDAQ:BLFS)

TearLab Corporation (NASDAQ:TEAR) expects to announce its Q1 2014 financial results after market closes on Thursday May 8, 2014. TearLab Corporation (NASDAQ:TEAR) is pleased to invite all willing participants in a conference call during which time financial results will be discussed. TearLab Corp (NASDAQ:TEAR) stock performance was -7.61% in last session and finished the day at $4.98. Traded volume was 779,893.00million shares in the last … Continue reading Healthcare Losers: TearLab Corp (NASDAQ:TEAR), Galectin Therapeutics (NASDAQ:GALT), Fibrocell Science (NYSEMKT:FCSC), BioLife Solutions (NASDAQ:BLFS)

Mark DeFrance